Tocqueville Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Tocqueville Asset Management's IBB Position: Q3 2024 in Review
Tocqueville Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 20,016 shares — an estimated $2.75M sold.
Tocqueville Asset Management first reported a position in IBB in Q4 2019 and held it in 19 quarters. The position peaked at $6.41M in Q2 2021. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.
- Tocqueville Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
- Tocqueville Asset Management sold 20,016 iShares Biotechnology ETF shares in Q3 2024, an estimated $2.75M.
- Tocqueville Asset Management first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 19 quarters.
- Tocqueville Asset Management's iShares Biotechnology ETF position peaked at $6.41M in Q2 2021.
- 893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.
Based on Tocqueville Asset Management's 13F filing for Q3 2024, filed 8 Nov 2024.